{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:56:40Z","timestamp":1759384600330},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.2020-8-3","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T09:10:58Z","timestamp":1600247458000},"page":"1-12","source":"Crossref","is-referenced-by-count":12,"title":["Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL* protocol"],"prefix":"10.7573","volume":"9","author":[{"given":"Teodoro","family":"Iturbe-Hernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Garc\u00eda de Guadiana Romualdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Gil Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Mart\u00ednez Franc\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Meca Birlanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Cerezo-Manchado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10047","published-online":{"date-parts":[[2020,9,18]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2020\/11\/dic.2020-8-3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T19:18:38Z","timestamp":1604344718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/dabigatran-the-oral-anticoagulant-of-choice-at-discharge-in-patients-with-non-valvular-atrial-fibrillation-and-covid-19-infection-the-anibal-protocol"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.2020-8-3","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]}}}